| Name | Title | Contact Details |
|---|
Skagit Regional Health includes Skagit Valley Hospital, Skagit Regional Clinics and Cascade Valley Hospital. Skagit Regional Health is a health care leader in Northwest Washington, providing advanced, quality and comprehensive services to the people of our communities. Skagit Valley Hospital is home to the area`s only cardiac catheterization labs and offers advanced heart and vascular care. Skagit Valley Hospital leads the way in comprehensive cancer care and is a network member of the Seattle Cancer Care Alliance, which brings together the talents and research power of Fred Hutchinson Cancer Research Center, UW Medicine and Seattle Children`s. Skagit Valley Hospital is licensed for 137 beds, features a full range of services including comprehensive cancer care; surgical services; a Level III Emergency Department; a well-appointed Family Birth Center; comprehensive diagnostics; and advanced heart and vascular care. Skagit Regional Clinics is a network of 19 health care facilities providing primary and specialty outpatient care in north Snohomish, Island and Skagit counties. Cascade Valley Hospital is a 48-bed acute care facility in Arlington, with a free-standing surgery center and wound care center. Cascade Valley Hospital provides acute, critical care, general surgery, a level IV Emergency Department, and Family Birthing Center, plus a wide array of outpatient and diagnostic imaging services. Skagit Regional Health is Skagit County`s largest employer and the third largest public district hospital in the State of Washington.
The California Poison Control System (CPCS) is a San Francisco, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Avalon Healthcare is a Tampa, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Envisia Therapeutics, formed by Liquidia Technologies in 2013, is a privately held biotechnology company focused on the development of novel ocular therapies. Envisia is leveraging the unique and powerful properties of the PRINT® platform to develop therapies for a variety of ocular conditions, the most advanced of which is ENV515, for the treatment of glaucoma. ENV515 is a novel extended-release formulation of a prostaglandin analogue formulation. It has the potential to significantly limit disease progression and vision loss through improved product performance and patient compliance. Envisia is located in Research Triangle Park, North Carolina.
Pacific Ambulance is a Lake Forest, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.